Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 6
2004 8
2005 19
2006 22
2007 9
2008 23
2009 20
2010 21
2011 12
2012 24
2013 20
2014 19
2015 18
2016 21
2017 26
2018 36
2019 32
2020 26
Text availability
Article attribute
Article type
Publication date

Search Results

333 results
Results by year
Filters applied: . Clear all
Page 1
CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum.
Jiang Y, Qian F, Yang J, Liu Y, Dong F, Xu C, Sun B, Chen B, Xu X, Li Y, Wang R, Yang S. Jiang Y, et al. Among authors: Dong F. Nat Commun. 2017 May 4;8:15179. doi: 10.1038/ncomms15179. Nat Commun. 2017. PMID: 28469274 Free PMC article.
Chen H, Bai J, Dong F, Fang H, Zhang Y, Meng W, Liu B, Luo Y, Liu M, Bai Y, Abdul-Ghani MA, Li R, Wu J, Zeng R, Zhou Z, Dong LQ, Liu F. Chen H, et al. Among authors: Dong F, Dong LQ. FASEB J. 2017 Sep;31(9):4203. doi: 10.1096/fj.201600985RERR. FASEB J. 2017. PMID: 28860308 Free PMC article. No abstract available.
Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R, Yang N, Kong B, Cao B, Feng D, Yu X, Ge C, Huang J, Shen J, Wang P, Feng S, Fei F, Guo J, He J, Aa N, Chen Q, Pan Y, Schumacher JD, Yang CS, Guo GL, Aa J, Wang G. Sun R, et al. Among authors: Feng D, Feng S. Mol Pharmacol. 2017 Feb;91(2):110-122. doi: 10.1124/mol.116.106617. Epub 2016 Dec 8. Mol Pharmacol. 2017. PMID: 27932556 Free PMC article.
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies.
Chao MP, Takimoto CH, Feng DD, McKenna K, Gip P, Liu J, Volkmer JP, Weissman IL, Majeti R. Chao MP, et al. Among authors: Feng DD. Front Oncol. 2020 Jan 22;9:1380. doi: 10.3389/fonc.2019.01380. eCollection 2019. Front Oncol. 2020. PMID: 32038992 Free PMC article. Review.
Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity.
Pai CS, Simons DM, Lu X, Evans M, Wei J, Wang YH, Chen M, Huang J, Park C, Chang A, Wang J, Westmoreland S, Beam C, Banach D, Bowley D, Dong F, Seagal J, Ritacco W, Richardson PL, Mitra S, Lynch G, Bousquet P, Mankovich J, Kingsbury G, Fong L. Pai CS, et al. Among authors: Dong F. J Clin Invest. 2019 Jan 2;129(1):349-363. doi: 10.1172/JCI123391. Epub 2018 Dec 10. J Clin Invest. 2019. PMID: 30530991 Free PMC article.
Genome-Wide CRISPR-Cas9 Screening Identifies NF-κB/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma.
Huang K, Liu X, Li Y, Wang Q, Zhou J, Wang Y, Dong F, Yang C, Sun Z, Fang C, Liu C, Tan Y, Wu X, Jiang T, Kang C. Huang K, et al. Among authors: Dong F. Adv Sci (Weinh). 2019 Jul 24;6(17):1900782. doi: 10.1002/advs.201900782. eCollection 2019 Sep 4. Adv Sci (Weinh). 2019. PMID: 31508283 Free PMC article.
333 results
Jump to page